Home / Stocks / Rays Of Belief Limited
MOMSBELIEF

Rays Of Belief Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹274.0

Change

-10.42 (-3.66%)

Open

₹287.0

Prev. Close

₹284.42

Day High

₹287.95

Day Low

₹270.06

Volume Analysis

Traded

194,485

Delivered

88,910

Delivery %

45.72%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (54.5%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹302.51 ₹295.23 ₹284.62 ₹277.34 ₹266.73 ₹259.45 ₹248.84
Fibonacci ₹295.23 ₹288.4 ₹284.17 ₹277.34 ₹270.51 ₹266.28 ₹259.45
Camarilla ₹278.92 ₹277.28 ₹275.64 ₹277.34 ₹272.36 ₹270.72 ₹269.08

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-7.38%

1 Month

+0.01%

3 Months

—

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹77.11

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

14.68%

Net margin 6.07% × asset turnover 1.39x × equity multiplier 1.74x

Company Overview

Sector

Healthcare

Market Cap

₹615 Cr

P/E (TTM)

99.3

ROE

16.1%

Book Value

₹73.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Rays Of Belief Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 59/100. The strongest factor is Financial Strength (100/100), while Cash Flow (3/100) is the weakest area to weigh before deciding. Strong 3-year revenue growth (54.5%).

TopFund Score — Fundamentals Quality

59/100 — Average

Data confidence: 72/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

100

Valuation

24

Cash Flow

3

Corporate Governance

50

Momentum

82

Institutional Ownership

19

Business Quality

63

Risk & Volatility

63

Liquidity

38

From Screener.in

  • −Stock is trading at 4.02 times its book value

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

CARE report for quarter ended September 30, 2026 shows IPO proceeds utilized; no deviation detected.

Newspaper publication for Unaudited Financial Results for the Quarter and Half year ended September 30, 2026

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2025 Sep 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 11 23 25 25 27
Expenses + 10 19 20 20 21
Operating Profit 0 4 5 5 6
OPM % 4.39% 18.7% 19.11% 19.83% 22.26%
Other Income + 0 0 0 0 0
Interest 0 0 0 0 1
Depreciation 1 1 1 1 1
Profit before tax 0 3 3 4 5
Tax % 47.22% 20.79% 30.41% 25.87% 27.27%
Net Profit + -1 2 2 3 3
EPS in Rs 0 1 2 2 2
Raw PDF — — — — —
YoY Sales growth — — — 136 18

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026
Sales + 22 31 36 82
Expenses + 29 29 34 69
Operating Profit -7 2 3 12
OPM % -32.35% 5.13% 7.63% 15.14%
Other Income + 0 0 0 0
Interest 0 0 1 2
Depreciation 1 1 2 4
Profit before tax -8 0 0 7
Tax % 0.0% -750.0% -7,000.0% 28.08%
Net Profit + -8 1 6 5
EPS in Rs -5 1 4 3
Dividend Payout % 0.0% 0.0% 0.0% 0.0%
Sales growth — 38 19 —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 Sep 2026
Reserves 4 5 15 15 132
Borrowings + 1 2 7 9 26
Other Liabilities + 2 5 5 11 28
Total Liabilities 8 13 26 51 207
Fixed Assets + 2 4 4 12 32
CWIP 0 0 0 0 0
Investments 0 0 0 0 0
Other Assets + 6 9 22 39 175
Total Assets 8 13 26 51 207
Equity Capital 0 0 0 16 21

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026
Cash from Operating Activity + -7 2 -2 -2
Cash from Investing Activity + 2 -3 -2 -6
Cash from Financing Activity + 8 1 5 6
Net Cash Flow 2 0 1 -2
Free Cash Flow -8 1 -4 -3
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 96 140 -64 -15

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

  Sep 2026
Public 18.42%
Promoters 68.77%
FII 2.4%
DII 10.42%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Rays Of Belief Limited (this stock) 615 99.3 4.03 16.1%
Fabtech Technologies Ltd 609 20.5 1.39 12.0%
Valiant Laboratories Ltd 570 35.2 1.72 -2.55%
Wanbury Limited 676 20.3 4.3 76.5%
Haleos Labs Limited 494 38.1 2.25 8.44%
Gaudium Ivf N Women H L 740 32.0 4.55 24.6%
Zim Laboratories Limited 756 365.0 2.59 1.59%

Which Mutual Funds Hold Rays Of Belief Limited?

Frequently Asked Questions about Rays Of Belief Limited

Community Sentiment

What are other investors saying about Rays Of Belief Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.